Pangenomic Health Inc.
PGHIF
$1.46
$0.3632.74%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 0.31% | -1.22% | |||
| Gross Profit | -0.31% | 1.22% | |||
| SG&A Expenses | 17.24% | -53.65% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 16.25% | -52.17% | |||
| Operating Income | -16.25% | 52.17% | |||
| Income Before Tax | -6.53% | 51.17% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -6.53% | 51.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -6.53% | 51.17% | |||
| EBIT | -16.25% | 52.17% | |||
| EBITDA | -16.25% | 52.17% | |||
| EPS Basic | -7.44% | 70.56% | |||
| Normalized Basic EPS | -7.95% | 70.57% | |||
| EPS Diluted | -7.44% | 70.56% | |||
| Normalized Diluted EPS | -7.95% | 70.57% | |||
| Average Basic Shares Outstanding | -0.85% | 65.74% | |||
| Average Diluted Shares Outstanding | -0.85% | 65.74% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||